2Trifanescu RA, Poiana C. Update in endocrinology - primary hyperaldosteronism - from secondary hypertension towards metabolic syndrome and beyond[ J]. Maedica (Buchar), 2012, 7 (1) :90-91.
3Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism [J]. J Am Coil Cardiol, 2005, 45(8) :1243-1248.
4Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline[ J]. J Clin Endocrinol Metab, 2008, 93(9):3266-3281.
5Campbell DJ, Nussberger J, Stowasser M, et al. Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement[ J ]. Clin Chem, 2009, 55 (5) :867-877.
6Gruson D, Maisin D, Lison P, et al. Two-site automated ehemiluminescent assay for measurement of immunoreactive renin [J]. Biomarkers, 2011, 16(7) :605-609.
7Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline [ J ]. J Clin Endocrinol Metab, 2008, 93 ( 5 ) : 1526- 1540.
8Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline [J]. J Clin Endocrinol Metab, 2014, 99(6) :1915-1942.
9Rossi GP, Barisa M, Belfiore A, et al. The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma [ J ] . J Hypertens, 2010, 28(9) :1892-1899.
10Perschel FH, Schemer R, Seiler L, et al. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays[ J]. Clin Chem, 2004, 50(9) : 1650-1655.
